APIs’ Intermediates
|
NO. |
Product name |
CAS No. |
Molecular formula |
Intermediates of Ledipasvir
|
◇ |
(S)-tert-butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl) -5-azaspiro[2.4]heptane-5-carboxylate |
1441670-89-8 |
C27H26BrF2N3O2
|
◇ |
N-[(1S)-1-[[(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]carbamic acid methyl ester |
1256388-50-7 |
|
Intermediates of Daclatasvir
|
◇ |
1H-Imidazole, 5,5’-[1,1’-biphenyl]-4,4’-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4) |
1009119-83-8 |
C26H32Cl4N6
|
◇ |
4,4'-Bis(2-bromoacetyl)biphenyl |
4072-67-7 |
C16H12Br2O2
|
◇ |
N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride |
1009119-65-6 |
|
Intermediates of Tofacitinib
|
◇ |
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine |
3680-69-1 |
C6H4ClN3
|
◇ |
(3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride |
1062580-52-2 |
C14H24Cl2N2·2(HCl)
|
◇ |
(2R,3R)-2,3-bis[(4-methylbenzoyl)oxy] butanedioic acid compd. with (3R,4R)-N,4- dimethyl-1-(phenylmethyl)-3-piperidinamine |
477600-71-8 |
|
Intermediates of Fondaparinux sodium
|
◇ |
Methyl 6-o-acetyl-3-o-benzyl-2-benzyloxycarbonylamino- 2-deoxy- a-d-glucopyranose |
114869-95-3 |
C24H29NO8
|
Intermediate of Indacaterol
|
◇ |
2-Aminoindan hydrochloride |
2338-18-3 |
C9H12ClN
|
Velpatasvir intermediates
|
◇ |
4-Bromo-n-methoxy-n,3-dimethylbenzamide |
170230-01-0 |
C10H12BrNO2
|
◇ |
9-Bromo-3-(2-bromoacetyl)-10,11-dihydro-5H-benzo[d]naphtho[2,3-b]pyran-8(9H)-one |
1438383-89-1 |
C19H14Br2O3
|
◇ |
Carbamic acid, N-[(1R)-2-[(2S,4S)-2-[4-[1,11-dihydro-2-[(2S,5S)-1- [(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4',3':6,7]naphth[1,2-d]imidazol-9-yl]-1H |
1377049-84-7 |
C49H54N8O8
|
◇ |
(2S,4S)-2-[5-[1,11-Dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4',3':6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxym |
1378391-45-7 |
|
◇ |
(2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid |
1378388-16-9 |
|
|
◇ |
2-(2-Ethoxyphenoxy)ethyl bromide |
3259-03-8 |
C10H13BrO2
|
◇ |
R-(-)-5-(2-amino-propyl)-2-methoxy-benzenesulfonamide |
112101-81-2 |
C10H13NO4S
|
Intermediates of Lenalidomide
|
◇ |
Methyl 2-bromomethyl-3-nitrobenzoate |
98475-07-1 |
C9H8BrNO4
|
Ribociclib’s intermediates
|
◇ |
Ribociclib Succinate |
1374639-75-4 |
|
◇ |
2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide |
1211443-61-6 |
|
◇ |
4-[6-[[7-cyclopentyl-6-[(dimethylamino)carbonyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-pyridinyl]-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester |
1374639-78-7 |
|
◇ |
2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid |
1211443-58-1 |
|
◇ |
Ribociclib base |
1211441-98-3 |
|
◇ |
(2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol |
1374639-77-6 |
|
Abemaciclib’s Intermediates
|
◇ |
4-[6-[[7-cyclopentyl-6-[(dimethylamino)carbonyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-pyridinyl]-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester |
1231930-37-2 |
|
◇ |
5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-amine |
1180132-17-5 |
|
◇ |
6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole |
1231930-33-8 |
|
◇ |
6-(2-chloro-5-fluoropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole |
1231930-42-9 |
|
Sacubitril-Valsartan (LCZ696)’s intermediates
|
◇ |
Sacubitril-Valsartan (LCZ696) |
936623-90-4 |
|
◇ |
(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-50-2 |
|
◇ |
(2R,4S)-4-Amino-5-(biphenyl-4-yl)-2-methylpentanoic acid ethyl ester hydrochloride |
149690-12-0 |
|
◇ |
(alphaR,gammaS)-gamma-[(3-Carboxy-1-oxopropyl)amino]-alpha-methyl-[1,1'-biphenyl]-4-pentanoic acid 4-ethyl ester calcium salt (2:1) |
1369773-39-6 |
|
Roxadustat and Intermediates
|
◇ |
4-Hydroxy-7-phenoxy-3-isoquinolinecarboxyli c acid methyl ester |
1455091-10-7 |
|
◇ |
1-Methyl-4-hydroxy-7-phenoxy isoquinoline-3-methyl formate |
1421312-34-6 |
|
◇ |
4-Phenoxy-1,2-benzenedicarboxylic acid |
37951-15-8 |
|
◇ |
5-phenoxyisobenzofuran-1(3H)-one |
57830-14-5 |
C14H10O3
|
◇ |
Ethyl 1,4-dihydroxy-7-phenoxyisoquinoline-3-carboxylate |
|
|
◇ |
Ethyl 1-chloro-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate |
|
|
◇ |
4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid ethyl ester |
1809286-36-9 |
|
Intermediates of Acalabrutinib
|
◇ |
(3-Chloropyrazin-2-yl) Methanamine hydrochloride |
939412-86-9 |
C5H7Cl2N3
|
◇ |
(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester |
1420478-88-1 |
|
◇ |
[4-[(Pyridin-2-yl)carbamoyl]phenyl]boronic acid |
850568-25-1 |
C12H11BN2O3
|
◇ |
N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide |
1383385-64-5 |
|
◇ |
(S)-benzyl 2-((3-chloropyrazin-2-yl)methylcarbamoyl)pyrrolidine-1-carboxylate |
1418307-17-1 |
|
◇ |
4-[8-amino-3-(2S)-2-pyrrolidinylimidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-Benzamide |
1420478-90-5 |
|
Elagolix and Its Intermediates
|
◇ |
Elagolix Sodium |
832720-36-2 |
C32H29F5N3NaO5
|
◇ |
N-[[2-Fluoro-6-(trifluoromethyl)phenyl]methyl]urea |
830346-46-8 |
C9H8F4N2O
|
◇ |
2-Fluoro-3-methoxybenzeneboronic acid |
352303-67-4 |
C7H8BFO3
|
◇ |
1-(2-Fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H- pyrimidine-2,4-dione |
830346-47-9 |
C13H10F4N2O2
|
◇ |
5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione |
830346-48-0 |
C13H9BrF4N2O2
|
◇ |
1-(2-fluoro-6-(trifluoromethyl)benzyl)-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione |
1150560-54-5 |
|
◇ |
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione |
1150560-59-0 |
|
Intermediates of Lorlatinib
|
◇ |
(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione Tosylate |
1803573-19-4 |
|
◇ |
2-(bis(tert-butoxycarbonyl)amino)-5-bromopyridin-3-yl4-methylbenzenesulfonate |
1803573-21-8 |
|
◇ |
1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrilehydrochloridesalt |
1643141-20-1 |
|
Upadacitinib and Its Intermediates
|
◇ |
Upadacitinib |
1310726-60-3 |
|
◇ |
2-bromo-5H-Pyrrolo[2,3-b]pyrazine |
875781-43-4 |
|
◇ |
2-Bromo-5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazine |
1201186-54-0 |
|
◇ |
N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester |
1869118-24-0 |
|
◇ |
(3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid Dicyclohexylamine Salt |
2095311-49-0 |
|
◇ |
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester |
1428243-26-8 |
|
◇ |
Tert-butyl (5-(p-toluenesulfonyl)-5H-pyrrolo [2,3-b]pyrazin-2-yl)carbamate |
1201187-44-1 |
|
◇ |
8-[(3R,4S)-4-ethyl-3-pyrrolidinyl]-3H-Imidazo[1,2-A]pyrrolo[2,3-E]pyrazine hydrochloride (1:2) |
2050038-84-9 |
|
◇ |
(3R,4S)-4-Ethyl-1,3-pyrrolidinedicarboxylic acid 1-(phenylmethyl) ester (alphaR)-alpha-methyl-1-naphthalenemethanamine |
1428243-25-7 |
|
◇ |
(3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid |
1428243-24-6 |
|
Darolutamide and Intermediates
|
◇ |
Darolutamide |
1297538-32-9 |
|
◇ |
2-chloro-4-(1H-pyrazol-3-yl)benzonitrile |
1297537-37-1 |
|
◇ |
(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile |
1297537-41-7 |
|
◇ |
5-acetyl-1H-pyrazole-3-carboxylic acid |
1297537-45-1 |
|
◇ |
(S)-5-acetyl-N-(1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-1H-pyrazole-3-carboxamide |
1297537-33-7 |
|